Logo image of CCV

CHURCHILL CAPITAL CORP V-A (CCV) Stock Fundamental Analysis

NYSE:CCV - New York Stock Exchange, Inc. - US17144T1079 - Common Stock - Currency: USD

10.395  +0.01 (+0.14%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to CCV. CCV was compared to 0 industry peers in the Unkown industry. CCV has a bad profitability rating. Also its financial health evaluation is rather negative. CCV has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CCV was profitable.
In the past year CCV has reported a negative cash flow from operations.
CCV Yearly Net Income VS EBIT VS OCF VS FCFCCV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 0 5M 10M 15M 20M

1.2 Ratios

Industry RankSector Rank
ROA 4.92%
ROE 6.12%
ROIC N/A
ROA(3y)1.41%
ROA(5y)N/A
ROE(3y)1.46%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CCV Yearly ROA, ROE, ROICCCV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 0 2 4

1.3 Margins

CCV does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CCV Yearly Profit, Operating, Gross MarginsCCV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022

More info and screens

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, CCV has about the same amount of shares outstanding.
CCV has a worse debt/assets ratio than last year.
CCV Yearly Shares OutstandingCCV Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 20M 40M 60M
CCV Yearly Total Debt VS Total AssetsCCV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 100M 200M 300M 400M 500M

2.2 Solvency

CCV has an Altman-Z score of 5.32. This indicates that CCV is financially healthy and has little risk of bankruptcy at the moment.
CCV has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 5.32
ROIC/WACCN/A
WACCN/A
CCV Yearly LT Debt VS Equity VS FCFCCV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 0 100M 200M 300M 400M

2.3 Liquidity

CCV has a Current Ratio of 0.07. This is a bad value and indicates that CCV is not financially healthy enough and could expect problems in meeting its short term obligations.
CCV has a Quick Ratio of 0.07. This is a bad value and indicates that CCV is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.07
Quick Ratio 0.07
CCV Yearly Current Assets VS Current LiabilitesCCV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 500K 1M 1.5M

More info and screens

0

3. Growth

3.1 Past

CCV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -87.93%.
EPS 1Y (TTM)-87.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-65.07%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CCV Yearly Revenue VS EstimatesCCV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022
CCV Yearly EPS VS EstimatesCCV Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CCV is valuated quite expensively with a Price/Earnings ratio of 129.94.
CCV is valuated expensively when we compare the Price/Earnings ratio to 29.63, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 129.94
Fwd PE N/A
CCV Price Earnings VS Forward Price EarningsCCV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CCV Per share dataCCV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CCV!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHURCHILL CAPITAL CORP V-A

NYSE:CCV (10/16/2023, 8:19:04 PM)

10.395

+0.01 (+0.14%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)08-11 2023-08-11
Earnings (Next)N/A N/A
Inst Owners0.13%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap283.58M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 129.94
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.32
P/tB 2.32
EV/EBITDA N/A
EPS(TTM)0.08
EY0.77%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.15
FCFYN/A
OCF(TTM)-0.15
OCFYN/A
SpS0
BVpS4.48
TBVpS4.48
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.92%
ROE 6.12%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)1.41%
ROA(5y)N/A
ROE(3y)1.46%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.07
Quick Ratio 0.07
Altman-Z 5.32
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-87.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-65.07%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y1.76%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y40.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y40.06%
OCF growth 3YN/A
OCF growth 5YN/A